Active Non-Intrusive System Identification for Cardiovascular Monitoring: Part II — Development of System Identifiction Algorithm

Author(s):  
Nima Fazeli ◽  
Jin-Oh Hahn

In this paper, we present an innovative active non-intrusive system identification approach to cardiovascular monitoring. The proposed approach is based on a dual collocated actuator-sensor system for cardiovascular system identification, in which the actuators actively excite the arterial tree to create rich and informative trans-mural pressure waves traveling in the arterial tree, which are then non-intrusively measured by the collocated sensors. In our previous work, we developed a mathematical model to reproduce the propagation of intra-vascular (arterial) and extra-vascular (artificial) pressure waves along the arterial tree. Then, we used a dual (radial-femoral) blood pressure cuff system as a prototype dual collocated actuator-sensor system to demonstrate the proposed methodological framework to create rich trans-mural pressure waves as well as to non-intrusively reconstruct them from sensor measurements. In this follow-up work, we propose a novel system identification algorithm to derive cardiovascular system dynamics and reconstruct central aortic blood pressure waveform from the trans-mural pressure waves observed at the peripheral locations. It was successfully demonstrated that the system identification algorithm was able to reconstruct the central aortic blood pressure accurately, and that its performance was superior to the passive non-intrusive approach.

Author(s):  
Zahra Ghasemi ◽  
Chang-Sei Kim ◽  
Eric Ginsberg ◽  
John Duell ◽  
Anuj Gupta ◽  
...  

This paper presents a model-based system identification approach to estimation of central aortic blood pressure waveform from non-invasive cuff pressure oscillation signals. First, we developed a mathematical model that can reproduce the relationship between central aortic blood pressure waveform and non-invasive cuff pressure oscillation signals at diametric locations by combining models to represent wave propagation in the artery, arterial pressure-volume relationship, and mechanics of the occlusive cuff. Second, we formulated the problem of estimating central aortic blood pressure waveform from non-invasive cuff pressure oscillation signals into a system identification problem. Third, we showed the proof-of-concept of the approach using simulated central aortic blood pressure waveform and cuff pressure oscillation signals. Finally, we illustrated the feasibility of the approach using central aortic blood pressure waveform and cuff pressure oscillation signals collected from a human subject. We showed that the proposed approach could estimate central aortic blood pressure waveform with accuracy: the root-mean-squared error associated with the central aortic blood pressure waveform was 1.7 mmHg (amounting to 1.6 % of the underlying mean blood pressure) while the errors associated with central aortic systolic and pulse pressures were −0.4 mmHg and −1.5 mmHg (amounting to −0.3 % and −1.4 % of the underlying mean blood pressure).


Author(s):  
Zahra Ghasemi ◽  
Chang-Sei Kim ◽  
Eric Ginsberg ◽  
Anuj Gupta ◽  
Jin-Oh Hahn

This paper presents a model-based blind system identification approach to estimation of central aortic blood pressure (BP) waveform from noninvasive diametric circulatory signals. First, we developed a mathematical model to reproduce the relationship between central aortic BP waveform and a class of noninvasive circulatory signals at diametric locations by combining models to represent wave propagation in the artery, arterial pressure–volume relationship, and mechanics of the measurement instrument. Second, we formulated the problem of estimating central aortic BP waveform from noninvasive diametric circulatory signals into a blind system identification problem. Third, we performed identifiability analysis to show that the mathematical model could be identified and its parameters determined up to an unknown scale. Finally, we illustrated the feasibility of the approach by applying it to estimate central aortic BP waveform from two diametric pulse volume recording (PVR) signals. Experimental results from ten human subjects showed that the proposed approach could estimate central aortic BP waveform accurately: the average root-mean-squared error (RMSE) associated with the central aortic BP waveform was 4.1 mm Hg (amounting to 4.5% of the underlying mean BP) while the average errors associated with central aortic systolic pressure (SP) and pulse pressure (PP) were 2.4 mm Hg and 2.0 mm Hg (amounting to 2.5% and 2.1% of the underlying mean BP). The proposed approach may contribute to the improved monitoring of cardiovascular (CV) health by enabling estimation of central aortic BP waveform from conveniently measurable diametric circulatory signals.


Circulation ◽  
2015 ◽  
Vol 132 (suppl_3) ◽  
Author(s):  
Bernard I. Levy ◽  
Jean-Guillaume Dillinger ◽  
Patrick Henry ◽  
Damien Logeart ◽  
Stephane Manzo Silberman ◽  
...  

Background: Treatment of hypertensive patients with beta-blockers reduces heart rate (HR) and increases central blood pressure, implying that the decrease in HR could explain reported increases in cardiovascular risk with beta-blocker. This analysis from a randomized, double-blind study explores whether HR reduction with the I f inhibitor ivabradine had an impact on central blood pressure and coronary perfusion. Methods and results: We included 12 normotensive patients with stable CAD, HR ≥70 bpm (sinus rhythm), and stable background beta-blocker therapy. Patients received ivabradine 7.5 mg bid or matched placebo for two 3-week periods with a crossover design and evaluation by aplanation tonometry. Treatment with ivabradine was associated with a significant reduction in resting HR after 3 weeks versus no change with placebo (-15.8±7.7 versus +0.3±5.8 bpm, p=0.0010). There was no relevant between-group difference in change in central aortic SBP (-4.0±9.6 versus +2.4±12.0 mm Hg, p=0.13) or augmentation index (-0.8±10.0% versus +0.3±7.6%, p=0.87). Treatment with ivabradine was associated with prolongation of diastolic perfusion time by 41% from baseline to 3 weeks (+215.6±105.3 versus -3.0±55.8 ms with placebo, p=0.0005) (Figure) and with a pronounced increase in an index of myocardial viability (Buckberg index, +39.3±27.6% versus -2.5±13.5% with placebo, p=0.0015). There were no safety issues during the study. Conclusion: Heart rate reduction with ivabradine does not modify central aortic blood pressure and is associated with a marked prolongation of diastolic perfusion time and an improvement in myocardial perfusion.


Sign in / Sign up

Export Citation Format

Share Document